Halozyme Therapeutics Inc. sell SVB Leerink LLC
Start price
13.05.25
/
50%
€48.64
Target price
13.05.26
€42.31
Performance (%)
22.49%
End price
14.05.26
€59.58
Summary
This prediction ended on 14.05.26 with a price of €59.58. The SELL prediction by SVB_Leerink_LLC finished with a performance of 22.49%. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Halozyme Therapeutics Inc. | 6.130% | 6.130% | 44.516% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) was downgraded by analysts at Leerink Partners from a "market perform" rating to an "underperform" rating. They now have a $47.00 price target on the stock.
Ratings data for HALO provided by MarketBeat
In the thread Trading Halozyme Therapeutics Inc.
Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten